FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1336610 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
15q13.3 microduplication syndrome (disorder) Preferred (foundation metadata concept)
15q14 microdeletion syndrome Preferred (foundation metadata concept)
15q14 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
15q24 deletion Acceptable (foundation metadata concept)
15q24 microdeletion Preferred (foundation metadata concept)
15q24 microdeletion syndrome Acceptable (foundation metadata concept)
15q26 deletion syndrome Acceptable (foundation metadata concept)
15q26.3 microdeletion syndrome Acceptable (foundation metadata concept)
16 Preferred (foundation metadata concept)
16 (AJCC) Acceptable (foundation metadata concept)
16 (UICC) Acceptable (foundation metadata concept)
16 (qualifier value) Preferred (foundation metadata concept)
16 Personality factor questionnaire Preferred (foundation metadata concept)
16 Personality factor questionnaire (assessment scale) Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone (substance) Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulfate Preferred (foundation metadata concept)
16 alpha-hydroxydehydroepiandrosterone sulfate (substance) Preferred (foundation metadata concept)
16 alpha-hydroxyestrone Preferred (foundation metadata concept)
16 alpha-hydroxyestrone (substance) Preferred (foundation metadata concept)
16 times a day Acceptable (foundation metadata concept)
16-alpha-Hydroxypregnenolone Preferred (foundation metadata concept)
16-alpha-Hydroxypregnenolone (substance) Preferred (foundation metadata concept)
16-alpha-Hydroxysteroid dehydrogenase Preferred (foundation metadata concept)
16-alpha-Hydroxysteroid dehydrogenase (substance) Preferred (foundation metadata concept)
16-alpha-hydroxyprogesterone dehydratase Preferred (foundation metadata concept)
16-alpha-hydroxyprogesterone dehydratase Acceptable (foundation metadata concept)
16-alpha-hydroxyprogesterone dehydratase (substance) Preferred (foundation metadata concept)
16-dehydroprogesterone hydratase Preferred (foundation metadata concept)
16-dehydroprogesterone hydratase (substance) Preferred (foundation metadata concept)
16-hydroxysteroid epimerase Preferred (foundation metadata concept)
16-hydroxysteroid epimerase (substance) Preferred (foundation metadata concept)
16-ketoandrostenediol Acceptable (foundation metadata concept)
16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase Preferred (foundation metadata concept)
16-methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase (substance) Preferred (foundation metadata concept)
16-oxoandrostenediol Preferred (foundation metadata concept)
16-oxoandrostenediol (substance) Preferred (foundation metadata concept)
16.1 Preferred (foundation metadata concept)
16.1 (qualifier value) Preferred (foundation metadata concept)
16.2 Preferred (foundation metadata concept)
16.2 (qualifier value) Preferred (foundation metadata concept)
16.58 Preferred (foundation metadata concept)
16.58 (qualifier value) Preferred (foundation metadata concept)
16.7 Preferred (foundation metadata concept)
16.7 (qualifier value) Preferred (foundation metadata concept)
16.8 Preferred (foundation metadata concept)
16.8 (qualifier value) Preferred (foundation metadata concept)
16/16 Preferred (foundation metadata concept)
16/22 Preferred (foundation metadata concept)
160 Preferred (foundation metadata concept)
160 (qualifier value) Preferred (foundation metadata concept)
1600 Preferred (foundation metadata concept)
1600 (qualifier value) Preferred (foundation metadata concept)
16000 Preferred (foundation metadata concept)
16000 (qualifier value) Preferred (foundation metadata concept)
162 Preferred (foundation metadata concept)
162 (qualifier value) Preferred (foundation metadata concept)
1627 Burgas Preferred (foundation metadata concept)
164-Yb Acceptable (foundation metadata concept)
165 Preferred (foundation metadata concept)
165 (qualifier value) Preferred (foundation metadata concept)
166 Preferred (foundation metadata concept)
166 (qualifier value) Preferred (foundation metadata concept)
166-Ho Acceptable (foundation metadata concept)
166-Yb Acceptable (foundation metadata concept)
166.667 Preferred (foundation metadata concept)
166.667 (qualifier value) Preferred (foundation metadata concept)
16600 Preferred (foundation metadata concept)
16600 (qualifier value) Preferred (foundation metadata concept)
16667 Preferred (foundation metadata concept)
16667 (qualifier value) Preferred (foundation metadata concept)
1667 Preferred (foundation metadata concept)
1667 (qualifier value) Preferred (foundation metadata concept)
167 Preferred (foundation metadata concept)
167 (qualifier value) Preferred (foundation metadata concept)
168 Preferred (foundation metadata concept)
168 (qualifier value) Preferred (foundation metadata concept)
1680 Preferred (foundation metadata concept)
1680 (qualifier value) Preferred (foundation metadata concept)
16800 Preferred (foundation metadata concept)
16800 (qualifier value) Preferred (foundation metadata concept)
169-Er Acceptable (foundation metadata concept)
169-Hf Acceptable (foundation metadata concept)
169-Yb Acceptable (foundation metadata concept)
16G Preferred (foundation metadata concept)
16G (qualifier value) Preferred (foundation metadata concept)
16PF - Personality factor questionnaire Acceptable (foundation metadata concept)
16p partial trisomy syndrome Preferred (foundation metadata concept)
16p partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
16p11.2 deletion syndrome Acceptable (foundation metadata concept)
16p11.2p12.2 microdeletion syndrome Preferred (foundation metadata concept)
16p11.2p12.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome (disorder) Preferred (foundation metadata concept)
16p12.1p12.3 triplication syndrome Preferred (foundation metadata concept)
16p12.1p12.3 triplication syndrome (disorder) Preferred (foundation metadata concept)
16p12.1p12.3 triplication syndrome is a rare chromosomal anomaly syndrome resulting from the partial triplication of the short arm of chromosome 16 characterized by global developmental delay, pre- or post-natal growth delay and distinctive craniofacial features, including short palpebral fissures, epicanthal folds, bulbous nose, thin upper vermillion border, apparently low-set ears and large ear lobes. Variable clinical features that have been reported include congenital heart disease, genitourinary abnormalities, visual anomalies or, less commonly, infantile hepatic disease. Patients are also reported to have tapered fingers. Preferred (foundation metadata concept)
16p12.2 microdeletion Acceptable (foundation metadata concept)
16p12.2 microdeletion syndrome Preferred (foundation metadata concept)
16p12.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
16p13.11 microdeletion syndrome Preferred (foundation metadata concept)

Start Previous Page 73 of 13367 Next End

Reference Sets

Reference set descriptor

Back to Start